Newsroom

Sorted by: Latest

-

Riassunto: SLB lancia ExaCT, il sistema di controllo elettrico delle CT per pozzi

HOUSTON--(BUSINESS WIRE)--SLB (NYSE: SLB) ha lanciato oggi il sistema di controllo elettrico delle tubazioni a spirale (CT) per pozzi ExaCT™, una piattaforma di intervento all'avanguardia che mette a disposizione il controllo elettrico in tempo reale nelle operazioni con tubazioni a spirale. Sostituendo l'attivazione idraulica a pressione con la comunicazione elettrica, l'erogazione energetica e la telemetria, il sistema ExaCT dà agli operatori maggiore visibilità, precisione e controllo, contr...
-

Mann Lake Ltd. Acquires Hive Hugger

HACKENSACK, Minn.--(BUSINESS WIRE)--Mann Lake Ltd., the world’s largest manufacturer and distributor of beekeeping supplies, today announced the acquisition of Hive Hugger, a company that developed an award-winning set of insulation products based on the condensing hive approach to beekeeping. Hive Hugger’s co-founder, Peggy DeSanto, will continue in her role as an active ambassador for the use of condensing hives. The concept of the condensing hive is to mimic the conditions of the tree caviti...
-

Reveal Launches Powerful Agentic AI Suite Automating eDiscovery from Preservation to Case Development

CHICAGO--(BUSINESS WIRE)--Reveal, the provider of integrated AI-native platforms spanning the eDiscovery and dispute resolutions lifecycles, today announced Reveal AI, an agentic suite that unifies capabilities across search and analysis, document review, insights and actions, and case development. Reveal AI brings together under a single, unified approach the AI technologies and analytics that legal teams have relied on for years, including aji for document review and ASK for fact-finding and...
-

Cycle Pharmaceuticals launches CAVHANZA™ (nilotinib) Orally Disintegrating Tablets (ODT), designed for use with PPIs and H₂RAs without food restrictions1

CAMBRIDGE, England--(BUSINESS WIRE)--Cycle Pharmaceuticals (Cycle) announces the launch of CAVHANZA in the United States, offering greater dosing flexibility and potential tolerability benefits for patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), while maintaining established efficacy at a 60% lower milligram strength than Tasigna® (nilotinib).2 Made in partnership with Flex Pharma (Flex), CAVHANZA offers a distinct option within the nilotinib landscape. Admini...
-

ZoomInfo Announces Updates to ZoomInfo MCP on Salesforce's AgentExchange

VANCOUVER, Wash.--(BUSINESS WIRE)--ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, today announced it has updated ZoomInfo MCP on Salesforce's AgentExchange, Salesforce's marketplace for the agentic era that brings together the rich ecosystems of AppExchange, Slack, and Agentforce into one experience, making it easy for customers to reach ZoomInfo's verified GTM data directly inside Slack AI, without switching tools. The relisted integration connects GTM.AI, ZoomInfo's headless GTM cont...
-

Imricor Supports HRS Call for Enhanced Radiation Protection and Urges a Future Beyond Radiation Exposure

MINNEAPOLIS--(BUSINESS WIRE)--Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), the pioneer in the interventional magnetic resonance (iMR) field, welcomed the Heart Rhythm Society’s call for the urgent and immediate adoption of enhanced radiation-protection measures for clinicians and staff working in fluoroscopy-based procedure environments.1 Imricor supports the use of enhanced radiation protection devices wherever fluoroscopy remains necessary. At the same time, the Company beli...
-

Shape Memory Medical獲得由August Global Partners領投的1000萬美元融資,推進主動脈臨床計畫

加州聖荷西--(BUSINESS WIRE)--(美國商業資訊)-- 專注於血管內栓塞治療的專有形狀記憶聚合物技術開發商Shape Memory Medical Inc.今日宣布,由新投資人August Global Partners (AGP)領投、新投資人Taiwania Capital跟投的1000萬美元可轉換票據融資已正式完成。 本次融資將為該公司主動脈產品組合的持續臨床開發提供資金,包括AAA-SHAPE關鍵性試驗中的病患隨訪和資料蒐集,以及FLAGSHIP可行性試驗的推進。Shape Memory Medical獲得了一個由全球醫療保健投資人組成的銀團的支援,其中包括HBM Healthcare Investments (Cayman) Ltd.、Earlybird Venture Capital和WexMed II, LLC。 Shape Memory Medical總裁兼執行長Ted Ruppel表示:「隨著我們進入對於本公司而言可能具有變革意義的階段,本次融資強化了我們的實力。AAA-SHAPE關鍵性試驗的招募工作近期已完成,FLAGSHIP試驗也持續推進,我們正專注...
-

Shape Memory Medical获得由August Global Partners领投的1000万美元融资,推进主动脉临床项目

加州圣何塞--(BUSINESS WIRE)--(美国商业资讯)-- 专注于血管内栓塞治疗的专有形状记忆聚合物技术开发商Shape Memory Medical Inc.今日宣布,由新投资者August Global Partners (AGP)领投、新投资者Taiwania Capital跟投的1000万美元可转换票据融资已正式完成。 本次融资将为该公司主动脉产品组合的持续临床开发提供资金,包括AAA-SHAPE关键性试验中的患者随访和数据收集,以及FLAGSHIP可行性试验的推进。Shape Memory Medical获得了一个由全球医疗保健投资者组成的银团的支持,其中包括HBM Healthcare Investments (Cayman) Ltd.、Earlybird Venture Capital和WexMed II, LLC。 Shape Memory Medical总裁兼首席执行官Ted Ruppel表示:“随着我们进入对于本公司而言可能具有变革意义的阶段,本次融资增强了我们的实力。AAA-SHAPE关键性试验的入组工作近期已完成,FLAGSHIP试验也持续推进,我们正...
-

GTM Investors Have Opportunity to Lead ZoomInfo Technologies Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES--(BUSINESS WIRE)--GTM Investors Have Opportunity to Lead ZoomInfo Technologies Inc. Securities Fraud Lawsuit with SBS Law...
-

BTU Investors Have Opportunity to Lead Peabody Energy Corporation Securities Fraud Lawsuit with SBS Law

LOS ANGELES--(BUSINESS WIRE)--BTU Investors Have Opportunity to Lead Peabody Energy Corporation Securities Fraud Lawsuit with SBS Law...